E/ kg/ dag (5 µ/ kg/ dag), der skal gives dagligt fra den første dag efter ophør af kemoterapi, indtil det forventede neutrofile nadir er passeret, og neutrofiltallet igen ligger inden for normalområdet.
The recommended dose of filgrastim for PBPC mobilisation after myelosuppressive chemotherapy is 0.5 MU/ kg/ day (5 μ g/ kg/ day) given daily from the first day after completion of chemotherapy until the expected neutrophil nadir is passed and the neutrophil count has recovered to the normal range.